Atenolol and Fasciitis - a phase IV clinical study of FDA data

Summary:

Fasciitis is reported as a side effect among people who take Atenolol (atenolol), especially for people who are male, 60+ old, also take Clopidogrel, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Fasciitis when taking Atenolol. It is created by eHealthMe based on reports of 170,420 people who have side effects when taking Atenolol from the FDA, and is updated regularly.

What is Atenolol?

Atenolol has active ingredients of atenolol. It is often used in high blood pressure. eHealthMe is studying from 176,618 Atenolol users. Check the latest studies of Atenolol.

What is Fasciitis?

Fasciitis (infection of muscle surrounding tissue) is found to be associated with 140 drugs and 259 conditions by eHealthMe. Check the latest studies of Fasciitis.

On Jul, 15, 2026

170,420 people reported to have side effects when taking Atenolol.
Among them, 37 people (0.02%) have Fasciitis.

Among these 37 people:

What is the gender of people who have Fasciitis when taking Atenolol? *

female: 11.76 %
male: 88.24 %

What is the age of people who have Fasciitis when taking Atenolol? *

What are other drugs people take besides Atenolol? *

What are other side effects people have besides Fasciitis? *

Muscle Spasms (muscle contraction): 19 people, 51.35%
Confusional State: 19 people, 51.35%
Diabetes Mellitus Inadequate Control: 18 people, 48.65%
Memory Loss: 18 people, 48.65%
Blood Glucose Increased: 18 people, 48.65%
Infection: 8 people, 21.62%
Anaemia (lack of blood): 8 people, 21.62%
Neuropathy Peripheral (surface nerve damage): 8 people, 21.62%
Injury: 8 people, 21.62%
Hyperlipidaemia (presence of excess lipids in the blood): 8 people, 21.62%

What are the existing conditions these people have? *

Type 2 Diabetes: 18 people, 48.65%
Pain: 7 people, 18.92%
Multiple Myeloma (cancer of the plasma cells): 7 people, 18.92%
Renal Cell Carcinoma (a kidney cancer): 5 people, 13.51%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.41%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 2.70%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 1 person, 2.70%
Neuropathy Peripheral (surface nerve damage): 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Atenolol and have Fasciitis?

- Check whether Fasciitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atenolol:

Atenolol (176,618 reports)

Fasciitis treatments and more:

Fasciitis (966 reports)

Browse all side effects of Atenolol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fasciitis:

Fasciitis (140 drugs)

Browse all the conditions that are associated with Fasciitis:

Fasciitis (259 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atenolol (the active ingredients of Atenolol) and Atenolol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.